Baxalta (United States)
Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
39%
Total
Publications
301
Total Open
Publications
118
Total
Citations
6.7K
Open Access
Percentage
39%
Total
Publications
301
Total Open
Publications
118
Total
Citations
6.7K
Breakdown
Publisher Open
19%
Both
17%
Other Platform Open
2%
Closed
62%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 20%
21
Hybrid 41%
43
No Guarantees 39%
40
Other Platform Open
Domain 72%
41
Other Internet 26%
15
Institution 16%
9
Preprint 4%
2
Public 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 41 |
DOI | Other Internet | 15 |
Universidade Estadual Paulista (Unesp) | Institution | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
University of Oxford | Institution | 1 |
University of Michigan–Ann Arbor | Institution | 1 |
University of Bristol | Institution | 1 |
uchile.cl OAI-PMH Repository | Institution | 1 |
Servicio Gallego de Salud | Institution | 1 |
Research Square | Preprint | 1 |